Download Scientific Program

ISGO Scientific Meeting Dec 2016, National Gallery of Ireland
Merrion Square, Dublin 2
December 2nd and 3rd 2016
“Translation and Innovation”
Friday 2nd December
09.00: Welcome
Session 1: Innovation Chairs: Noreen Gleeson, Matt Hewitt
09.15: “Surgical innovation” Prof. Ronan Cahill, Professor of Surgery, Mater Misericordiae University Hospital, UCD
09.45: “Medical Device Design at UCD - Minimally Invasive Access and Therapeutic Delivery Devices” Dr Eoin O’Cearbhall –
Biomedical Engineering, UCD
10.15: “Lessons in the metastatic cascade” Prof. John O’Leary, Professor of Pathology, TCD
Coffee: 10.45-11.05
Session 2: Surgical management peritoneal carcinomatosis. Session sponsored by
Chairs: Ian Harley, Donal Brennan
11.05 “Predicting optimal cytoreduction “.Prof Michael Birrer, Professor of Medicine at Harvard Medical School and Director of
Gillette Center for Gynecologic Oncology at Massachusetts General Hospital.
11:50: “Lessons learned from CRS and HIPEC for disseminated peritoneal malignancy – the Basingstoke experience” Mr
Brendan Moran, Director of Peritoneal Malignancy Institute, Basingstoke.
Lunch 12.35 – 13.15
CPD points applied for (RCPI)
ISGO Scientific Meeting Dec 2016, National Gallery of Ireland
Merrion Square, Dublin 2
December 2nd and 3rd 2016
13.15-14.00 – Session Sponsored by
“Current status of intraperitoneal chemotherapy for ovarian cancer post GOG 252”
Prof Bradley Monk, Director of the Division of Gynecologic Oncology, Creighton University School of Medicine, St. Joseph’s Hospital and
Medical Centre Phoenix, Arizona
Session 3: Survivorship Chairs: Charles Gilham, Dearbhaille O’ Donnell
14.00: “Weight loss – lessons learned from bariatric surgery” Prof. Carel LeRoux, Professor of Pathology, UCD.
14.30: “Exercise in BRCA mutation carriers” Dr David Gallagher, National Lead for Cancer Genetics (SJH / TCD)
15.00: “Pelvic Radiation Disease: progress in the management of GI consequences of treatment” Dr Jervoise Andreyev ,
Consultant Gastroenterologist in Pelvic Radiation Disease , Royal Marsden
Coffee :15.45-16.05
Session 4 : Thrombosis risk in Gynaecological Cancer – sponsored by the
16.05: “VTE in gynae cancer - who is at risk and when?”
Dr Feras Abu Saadeh, Consultant Gynaecological Oncologist, SJH.
16.30: “Guidelines for VTE prophylaxis in gynae cancer.” Dr. Kevin Ryan Haematologist SJH
17.05: “Can we predict VTE in gynae cancer?” Dr Lucy Norris, Dept of Obstetrics and Gynaecology, TCD
17:30 – 18.30: Science Foundation Ireland Networking workshop
19.00: Drinks reception + conference dinner in National Gallery of Ireland
CPD points applied for (RCPI)
ISGO Scientific Meeting Dec 2016, National Gallery of Ireland
Merrion Square, Dublin 2
December 2nd and 3rd 2016
Saturday 3rd December
Session 5:Submitted abstracts
Chairs: Michael O’Leary, Ruaidhri McVey
09.00-10.30: 6 x 12 minute talks
Session 6: Patient and Public Involvement Workshop
09.30-12.30: Georgian Rooms, National Gallery of Ireland
Session 7: Predicting therapeutic response Chairs: Donal Brennan, Cathy Kelly
11.00: “Novel targets in epithelial ovarian cancer” Prof. Michael Birrer, Professor of Medicine at Harvard Medical School and Director
of Gillette Center for Gynecologic Oncology at Massachusetts General Hospital.
11.45 “FKBPL – from the bench to phase 1 trial” Prof. Tracy Robson, Professor of Cancer Therapeutics, RCSI
12.15: “DNA damage response assay in High Grade Serous Ovarian Cancer“ Prof. Richard Kennedy, McClay Professor of Medical
Oncology, Queen's University Belfast.
Lunch: 12.45 – 13.15
Session 8: ISGO AGM – “The future of gynaecological oncology in Ireland”
13.30 -15.30
Surgical, Medical Oncology, Radiation Oncology, Palliative Care, Patient representative, Research, Allied health
15.30 – close of meeting
CPD points applied for (RCPI)